RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

2D Structure

Could not render structureView on PubChem

3D Structure

Loading 3D structure...

Chemical Identifiers

SMILES:

CC(C12CC3CC(C1)CC(C3)C2)N

InChI Key:

UBCHPRBFMUDMNC-UHFFFAOYSA-N

ClinicalTrials.gov PubMed

Clinical Development by Virus3

Influenza virus

Influenza

Target: Matrix protein 2

FDA approved

Preclinical

Phase 2positive

Phase 3positive

Approved

FDARussia

Approval ref: AntiviralDb

Influenza A virus

FLUAV

Target: Viral ion channel

FDA approved

Preclinical

Phase 2positive

Phase 3positive

Approved

FDARussia

PyV

Target: Unknown

Approved (other)

Preclinical

Phase 2

Phase 3

Approved

Russia